Intuitive Surgical, Inc.
Financials
Valuation Metrics
Intuitive Surgical, Inc.'s Market Cap is $139.25B. At end of 2025 it was $201.00B. Ranked #111 of 3,121 in US market (top 4%), #39 of 1,463 on NASDAQ (top 3%), #5 of 205 in Health Care Equipment & Services (top 2%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $139.25B | US#111/3,121 Sec#5/205 |
| Revenue | $11.03B | US#531/3,121 Sec#34/205 |
| Net Income | $3.14B | US#233/3,121 Sec#13/205 |
| Total Assets | $20.88B | US#605/3,121 Sec#28/205 |
| Net Assets | $18.17B | US#260/3,121 Sec#16/205 |
| Employees | 17,021 | US#620/3,121 Sec#45/205 |
| Value | ||
| P/E | 44.36x | US#1,849/3,121 Sec#90/205 |
| P/B | 7.66x | US#2,478/3,121 Sec#156/205 |
| PEG | 2.18x | US#1,062/3,121 Sec#51/205 |
| P/S | 12.62x | US#2,738/3,121 Sec#187/205 |
| EV/EBITDA | 30.29x | US#2,204/3,121 Sec#118/205 |
| FCF Yield | 2.31% | US#1,965/3,121 Sec#116/205 |
| Profitability | ||
| ROE | 17.28% | US#739/3,121 Sec#33/205 |
| ROA | 15.04% | US#224/3,121 Sec#11/205 |
| Op. Margin | 31.28% | US#483/3,121 Sec#8/205 |
| Revenue Growth | 20.66% | US#666/3,121 Sec#40/205 |
| Earnings Growth | 20.37% | US#856/3,121 Sec#45/205 |
| Financial Health | ||
| Debt Ratio | 14.19% | US#165/3,121 Sec#12/205 |
| Total Debt | $0.00 | US—/3,121 Sec—/205 |
| FCF | $3.22B | US#254/3,121 Sec#17/205 |
| Cash | $2.76B | US#323/3,121 Sec#18/205 |
| Current Ratio | 4.96x | US#477/3,121 Sec#38/205 |
| Net Debt/EBITDA | -0.61x | US#363/3,121 Sec#28/205 |
| Performance | ||
| 1Y Return | -9.79% | US#2,175/3,121 Sec#147/205 |
| 1M Return | -1.14% | US#1,210/3,121 Sec#107/205 |
| From 52W High | -34.89% | US#2,361/3,121 Sec#157/205 |
| 1Y MDD | -44.00% | US#2,211/3,121 Sec#130/205 |
| Trading | ||
| Volume | 2,668,029 shares | US#741/3,121 Sec#39/205 |
| Trading Value | $1.04B | US#101/3,121 Sec#6/205 |
| Per Share | ||
| EPS | $8.86 | US#341/3,121 Sec#23/205 |
| BPS | $51.30 | US#424/3,121 Sec#32/205 |
Company Info
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.